aluates Reports

$ 0.0

Automative

Metformin Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-38R863

Global Metformin Drugs Market Research Report 2020

BUY CHAPTERS

Metformin Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-38R863

Report

October 2024

Pages:122

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Apotex

Mallinckrodt plc

Teva Pharmaceuticals

Alkem

Dr. Reddy’s Laboratories

Atlas Pharmaceuticals

Sun Pharmaceutical Industries

Torrent Pharmaceuticals

Bristol–Myers Squibb

Viatris

Metformin Drugs - Market Size

The global market for Metformin Drugs was estimated to be worth US$ 3784 million in 2023 and is forecast to a readjusted size of US$ 2519.3 million by 2030 with a CAGR of -5.6% during the forecast period 2024-2030

Metformin Drugs - Market

Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Metformin Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metformin Drugs by region & country, by Type, and by Application.

The Metformin Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metformin Drugs.

Market Segmentation

Scope of Metformin Drugs - Market Report

Report Metric	Details
Report Name	Metformin Drugs - Market
Forecasted market size in 2030	US$ 2519.3 million
Forecasted years	2024 - 2030
Segment by Type:	50 Tablets 100 Tablets Other
Segment by Application	Hospital Drugs Stores
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Apotex, Viatris, Mallinckrodt, Teva Pharmaceuticals, Alkem, Dr. Reddy’s Laboratories, Atlas Pharmaceuticals, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Bristol-Myers Squibb
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metformin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Metformin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Metformin Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Metformin Drugs - Market size in 2030?

Ans: The Metformin Drugs - Market size in 2030 will be US$ 2519.3 million.

Who are the main players in the Metformin Drugs - Market report?

Ans: The main players in the Metformin Drugs - Market are Novartis, Apotex, Viatris, Mallinckrodt, Teva Pharmaceuticals, Alkem, Dr. Reddy’s Laboratories, Atlas Pharmaceuticals, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Bristol-Myers Squibb

What are the Application segmentation covered in the Metformin Drugs - Market report?

Ans: The Applications covered in the Metformin Drugs - Market report are Hospital, Drugs Stores

What are the Type segmentation covered in the Metformin Drugs - Market report?

Ans: The Types covered in the Metformin Drugs - Market report are 50 Tablets, 100 Tablets, Other

1 Market Overview

1.1 Metformin Drugs Product Introduction

1.2 Global Metformin Drugs Market Size Forecast

1.2.1 Global Metformin Drugs Sales Value (2019-2030)

1.2.2 Global Metformin Drugs Sales Volume (2019-2030)

1.2.3 Global Metformin Drugs Sales Price (2019-2030)

1.3 Metformin Drugs Market Trends & Drivers

1.3.1 Metformin Drugs Industry Trends

1.3.2 Metformin Drugs Market Drivers & Opportunity

1.3.3 Metformin Drugs Market Challenges

1.3.4 Metformin Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Metformin Drugs Players Revenue Ranking (2023)

2.2 Global Metformin Drugs Revenue by Company (2019-2024)

2.3 Global Metformin Drugs Players Sales Volume Ranking (2023)

2.4 Global Metformin Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Metformin Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Metformin Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Metformin Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Metformin Drugs

2.9 Metformin Drugs Market Competitive Analysis

2.9.1 Metformin Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Metformin Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metformin Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 50 Tablets

3.1.2 100 Tablets

3.1.3 Other

3.2 Global Metformin Drugs Sales Value by Type

3.2.1 Global Metformin Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Metformin Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Metformin Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Metformin Drugs Sales Volume by Type

3.3.1 Global Metformin Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Metformin Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Metformin Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Metformin Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Drugs Stores

4.2 Global Metformin Drugs Sales Value by Application

4.2.1 Global Metformin Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Metformin Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Metformin Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Metformin Drugs Sales Volume by Application

4.3.1 Global Metformin Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Metformin Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Metformin Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Metformin Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Metformin Drugs Sales Value by Region

5.1.1 Global Metformin Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Metformin Drugs Sales Value by Region (2019-2024)

5.1.3 Global Metformin Drugs Sales Value by Region (2025-2030)

5.1.4 Global Metformin Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Metformin Drugs Sales Volume by Region

5.2.1 Global Metformin Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Metformin Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Metformin Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Metformin Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Metformin Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Metformin Drugs Sales Value, 2019-2030

5.4.2 North America Metformin Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Metformin Drugs Sales Value, 2019-2030

5.5.2 Europe Metformin Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Metformin Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Metformin Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Metformin Drugs Sales Value, 2019-2030

5.7.2 South America Metformin Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Metformin Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Metformin Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Metformin Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Metformin Drugs Sales Value

6.2.1 Key Countries/Regions Metformin Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Metformin Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Metformin Drugs Sales Value, 2019-2030

6.3.2 United States Metformin Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Metformin Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Metformin Drugs Sales Value, 2019-2030

6.4.2 Europe Metformin Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Metformin Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Metformin Drugs Sales Value, 2019-2030

6.5.2 China Metformin Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Metformin Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Metformin Drugs Sales Value, 2019-2030

6.6.2 Japan Metformin Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Metformin Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Metformin Drugs Sales Value, 2019-2030

6.7.2 South Korea Metformin Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Metformin Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Metformin Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Metformin Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Metformin Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Metformin Drugs Sales Value, 2019-2030

6.9.2 India Metformin Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Metformin Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Novartis

7.1.1 Novartis Company Information

7.1.2 Novartis Introduction and Business Overview

7.1.3 Novartis Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Novartis Metformin Drugs Product Offerings

7.1.5 Novartis Recent Development

7.2 Apotex

7.2.1 Apotex Company Information

7.2.2 Apotex Introduction and Business Overview

7.2.3 Apotex Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Apotex Metformin Drugs Product Offerings

7.2.5 Apotex Recent Development

7.3 Viatris

7.3.1 Viatris Company Information

7.3.2 Viatris Introduction and Business Overview

7.3.3 Viatris Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Viatris Metformin Drugs Product Offerings

7.3.5 Viatris Recent Development

7.4 Mallinckrodt

7.4.1 Mallinckrodt Company Information

7.4.2 Mallinckrodt Introduction and Business Overview

7.4.3 Mallinckrodt Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Mallinckrodt Metformin Drugs Product Offerings

7.4.5 Mallinckrodt Recent Development

7.5 Teva Pharmaceuticals

7.5.1 Teva Pharmaceuticals Company Information

7.5.2 Teva Pharmaceuticals Introduction and Business Overview

7.5.3 Teva Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Teva Pharmaceuticals Metformin Drugs Product Offerings

7.5.5 Teva Pharmaceuticals Recent Development

7.6 Alkem

7.6.1 Alkem Company Information

7.6.2 Alkem Introduction and Business Overview

7.6.3 Alkem Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Alkem Metformin Drugs Product Offerings

7.6.5 Alkem Recent Development

7.7 Dr. Reddy’s Laboratories

7.7.1 Dr. Reddy’s Laboratories Company Information

7.7.2 Dr. Reddy’s Laboratories Introduction and Business Overview

7.7.3 Dr. Reddy’s Laboratories Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Dr. Reddy’s Laboratories Metformin Drugs Product Offerings

7.7.5 Dr. Reddy’s Laboratories Recent Development

7.8 Atlas Pharmaceuticals

7.8.1 Atlas Pharmaceuticals Company Information

7.8.2 Atlas Pharmaceuticals Introduction and Business Overview

7.8.3 Atlas Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Atlas Pharmaceuticals Metformin Drugs Product Offerings

7.8.5 Atlas Pharmaceuticals Recent Development

7.9 Sun Pharmaceutical Industries

7.9.1 Sun Pharmaceutical Industries Company Information

7.9.2 Sun Pharmaceutical Industries Introduction and Business Overview

7.9.3 Sun Pharmaceutical Industries Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Sun Pharmaceutical Industries Metformin Drugs Product Offerings

7.9.5 Sun Pharmaceutical Industries Recent Development

7.10 Torrent Pharmaceuticals

7.10.1 Torrent Pharmaceuticals Company Information

7.10.2 Torrent Pharmaceuticals Introduction and Business Overview

7.10.3 Torrent Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Torrent Pharmaceuticals Metformin Drugs Product Offerings

7.10.5 Torrent Pharmaceuticals Recent Development

7.11 Bristol-Myers Squibb

7.11.1 Bristol-Myers Squibb Company Information

7.11.2 Bristol-Myers Squibb Introduction and Business Overview

7.11.3 Bristol-Myers Squibb Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Bristol-Myers Squibb Metformin Drugs Product Offerings

7.11.5 Bristol-Myers Squibb Recent Development

8 Industry Chain Analysis

8.1 Metformin Drugs Industrial Chain

8.2 Metformin Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Metformin Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Metformin Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Novartis

Apotex

Mallinckrodt plc

Teva Pharmaceuticals

Alkem

Dr. Reddy’s Laboratories

Atlas Pharmaceuticals

Sun Pharmaceutical Industries

Torrent Pharmaceuticals

Bristol–Myers Squibb

Viatris

List of Tables

Table 1. Metformin Drugs Market Trends

Table 2. Metformin Drugs Market Drivers & Opportunity

Table 3. Metformin Drugs Market Challenges

Table 4. Metformin Drugs Market Restraints

Table 5. Global Metformin Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Metformin Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Metformin Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Metformin Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Metformin Drugs Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Metformin Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Metformin Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Metformin Drugs

Table 13. Global Metformin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metformin Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Metformin Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Metformin Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Metformin Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Metformin Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Metformin Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Metformin Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Metformin Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Metformin Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Metformin Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Metformin Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Metformin Drugs Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Metformin Drugs Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Metformin Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Metformin Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Metformin Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Metformin Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Metformin Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Metformin Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Metformin Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Metformin Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Metformin Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Metformin Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Metformin Drugs Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Metformin Drugs Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Metformin Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Metformin Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Metformin Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Metformin Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Metformin Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Metformin Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Metformin Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Metformin Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Metformin Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Metformin Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Metformin Drugs Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Metformin Drugs Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Metformin Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Metformin Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Metformin Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Metformin Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Metformin Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Novartis Company Information

Table 58. Novartis Introduction and Business Overview

Table 59. Novartis Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Novartis Metformin Drugs Product Offerings

Table 61. Novartis Recent Development

Table 62. Apotex Company Information

Table 63. Apotex Introduction and Business Overview

Table 64. Apotex Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Apotex Metformin Drugs Product Offerings

Table 66. Apotex Recent Development

Table 67. Viatris Company Information

Table 68. Viatris Introduction and Business Overview

Table 69. Viatris Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Viatris Metformin Drugs Product Offerings

Table 71. Viatris Recent Development

Table 72. Mallinckrodt Company Information

Table 73. Mallinckrodt Introduction and Business Overview

Table 74. Mallinckrodt Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Mallinckrodt Metformin Drugs Product Offerings

Table 76. Mallinckrodt Recent Development

Table 77. Teva Pharmaceuticals Company Information

Table 78. Teva Pharmaceuticals Introduction and Business Overview

Table 79. Teva Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Teva Pharmaceuticals Metformin Drugs Product Offerings

Table 81. Teva Pharmaceuticals Recent Development

Table 82. Alkem Company Information

Table 83. Alkem Introduction and Business Overview

Table 84. Alkem Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Alkem Metformin Drugs Product Offerings

Table 86. Alkem Recent Development

Table 87. Dr. Reddy’s Laboratories Company Information

Table 88. Dr. Reddy’s Laboratories Introduction and Business Overview

Table 89. Dr. Reddy’s Laboratories Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Dr. Reddy’s Laboratories Metformin Drugs Product Offerings

Table 91. Dr. Reddy’s Laboratories Recent Development

Table 92. Atlas Pharmaceuticals Company Information

Table 93. Atlas Pharmaceuticals Introduction and Business Overview

Table 94. Atlas Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Atlas Pharmaceuticals Metformin Drugs Product Offerings

Table 96. Atlas Pharmaceuticals Recent Development

Table 97. Sun Pharmaceutical Industries Company Information

Table 98. Sun Pharmaceutical Industries Introduction and Business Overview

Table 99. Sun Pharmaceutical Industries Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Sun Pharmaceutical Industries Metformin Drugs Product Offerings

Table 101. Sun Pharmaceutical Industries Recent Development

Table 102. Torrent Pharmaceuticals Company Information

Table 103. Torrent Pharmaceuticals Introduction and Business Overview

Table 104. Torrent Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Torrent Pharmaceuticals Metformin Drugs Product Offerings

Table 106. Torrent Pharmaceuticals Recent Development

Table 107. Bristol-Myers Squibb Company Information

Table 108. Bristol-Myers Squibb Introduction and Business Overview

Table 109. Bristol-Myers Squibb Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Bristol-Myers Squibb Metformin Drugs Product Offerings

Table 111. Bristol-Myers Squibb Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Metformin Drugs Downstream Customers

Table 115. Metformin Drugs Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Metformin Drugs Product Picture

Figure 2. Global Metformin Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Metformin Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Metformin Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Metformin Drugs Sales Price (2019-2030) & (USD/Unit)

Figure 6. Metformin Drugs Report Years Considered

Figure 7. Global Metformin Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Metformin Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Metformin Drugs Revenue in 2023

Figure 10. Metformin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 50 Tablets Picture

Figure 12. 100 Tablets Picture

Figure 13. Other Picture

Figure 14. Global Metformin Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Metformin Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Metformin Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Metformin Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Metformin Drugs Price by Type (2019-2030) & (USD/Unit)

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Drugs Stores

Figure 21. Global Metformin Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Metformin Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Metformin Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Metformin Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Metformin Drugs Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Metformin Drugs Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Metformin Drugs Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Metformin Drugs Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Metformin Drugs Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Metformin Drugs Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Metformin Drugs Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Metformin Drugs Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Metformin Drugs Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Metformin Drugs Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Metformin Drugs Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Metformin Drugs Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Metformin Drugs Sales Volume (%), (2019-2030)

Figure 38. United States Metformin Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Metformin Drugs Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Metformin Drugs Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Metformin Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Metformin Drugs Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Metformin Drugs Sales Value by Application (%), 2023 VS 2030

Figure 44. China Metformin Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Metformin Drugs Sales Value by Type (%), 2023 VS 2030

Figure 46. China Metformin Drugs Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Metformin Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Metformin Drugs Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Metformin Drugs Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Metformin Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Metformin Drugs Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Metformin Drugs Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Metformin Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Metformin Drugs Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Metformin Drugs Sales Value by Application (%), 2023 VS 2030

Figure 56. India Metformin Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Metformin Drugs Sales Value by Type (%), 2023 VS 2030

Figure 58. India Metformin Drugs Sales Value by Application (%), 2023 VS 2030

Figure 59. Metformin Drugs Industrial Chain

Figure 60. Metformin Drugs Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions